Cancer drugs provided under Rajasthan govt scheme sold in black market; probe ordered
Cancer drugs, costing up to ₹one lakh a vial, provided under Rajasthan’s government free-medicine programme were allegedly sold…
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor – Endpoints News
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor Endpoints NewsLilly to acquire Ajax…